
‘Development of new medicines lagging, drug resistance outpacing industry efforts’
Drug resistance is outpacing industrywide efforts, says Netherlandsbased Access to Medicine Foundation in its latest Antimicrobial Resistance (AMR) Benchmark report, even as it identified seven



